Tremfya 200 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1AY5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,292
Award facts
- Contract value 100% obligated
- $15,291.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,291.86 to AmerisourceBergen Drug Corp for TREMFYA 200 MG/2 ML Pen (2 mL), a pharmaceutical product used in the treatment of psoriasis and other immune-mediated inflammatory diseases. This non-set-aside, firm fixed-price contract was awarded on January 29, 2026, with an ultimate completion date of February 20, 2026. The contractor will perform work at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order execution under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving federal medical procurement needs across the Department of Defense healthcare system. The company maintains a comprehensive contract portfolio with the Defense Logistics Agency Medical Supply Chain, delivering a wide range of pharmaceutical products and medical supplies to military treatment facilities and veterans' healthcare programs. AmerisourceBergen's federal contracting demonstrates its competitive capability through open, non-set-aside awards spanning multiple therapeutic domains and transaction values, establishing it as a critical vendor for sustaining military and federal healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26F1AY5?
SPE2DR26F1AY5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F1AY5 worth?
The government has obligated $15,292 on SPE2DR26F1AY5.
Is contract SPE2DR26F1AY5 an order under another contract?
Yes. SPE2DR26F1AY5 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AY5 competed?
The extent of competition for SPE2DR26F1AY5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award